Nuzenio

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6 - MoomooMoomoo · Sat, 08 Aug 2026 06:51:06 GMT Lexicon Pharmaceuticals (NASDAQ:LXRX) Announces Earnings Results, Misses Estimates By $0.01 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:08:57 GMT Why Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 00:15:00 GMT Lexicon Pharmaceuticals (LXRX) Stockholders Plan to Sell 1.26M S - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:31:47 GMT LXRX SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Fri, 07 Aug 2026 04:47:01 GMT Lexicon Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $3.86, Implies 57% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:23 GMT Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:18:43 GMT Lexicon Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:03:57 GMT

Timeline

Sat, 08 Aug 2026 06:51:06 GMTPiper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6 - Moomoo

Sat, 08 Aug 2026 03:08:57 GMTLexicon Pharmaceuticals (NASDAQ:LXRX) Announces Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat

Sat, 08 Aug 2026 00:15:00 GMTWhy Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings - Yahoo Finance

Fri, 07 Aug 2026 09:31:47 GMTLexicon Pharmaceuticals (LXRX) Stockholders Plan to Sell 1.26M S - GuruFocus

Fri, 07 Aug 2026 04:47:01 GMTLXRX SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

Thu, 06 Aug 2026 23:20:23 GMTLexicon Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $3.86, Implies 57% Upside - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

LXRX26 live mentions Yahoo Finance Yahoo6 live mentions Finance6 live mentions Yahoo Finance Lexicon6 live mentions Pharmaceuticals5 live mentions Inc4 live mentions Earnings Call Highlights4 live mentions SONATA4 live mentions HCM Study4 live mentions EPS3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lexicon Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.